Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Rebetol

Rebetol
In stock
200mg
from A$148.43
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$178.12A$148.43
A$14.84 per tablet

In brief

  • In our pharmacy, you can buy rebetol without a prescription, with delivery across Australia in 9–21 days and discreet, anonymous packaging.
  • Rebetol (ribavirin) is used to treat chronic hepatitis C in combination with interferon or peginterferon; it is a nucleoside analogue antiviral that inhibits viral RNA synthesis and viral mRNA capping.
  • The usual dose for adults is weight-based: <75 kg — 1,000 mg/day (typically 400 mg in the morning and 600 mg in the evening); ≥75 kg — 1,200 mg/day (600 mg twice daily); paediatric dosing ~15 mg/kg/day divided; always given in combination with interferon/peginterferon and adjusted for renal impairment.
  • Administration is oral: Rebetol commonly supplied as 200 mg hard capsules and as an oral solution (40 mg/mL); an inhalation formulation (Virazole) exists for RSV but not for hepatitis C treatment.
  • Onset time: virological effects are usually detectable within 1–4 weeks of therapy; clinical improvement and sustained virological response develop over weeks to months.
  • Duration of action: ribavirin has a long terminal half-life (~120–170 hours); treatment courses are usually 24 weeks for genotypes 2–3 and 48 weeks for genotypes 1, 4, 5 and 6.
  • Alcohol warning: avoid alcohol during treatment and if you have liver disease — alcohol can worsen liver damage and increase treatment risks.
  • The most common side effect is fatigue (haemolytic anaemia is a common and clinically important adverse effect; other effects include headache, nausea and irritability).
  • Would you like to try rebetol without a prescription?

Basic Rebetol Information

  • INN (International Nonproprietary Name): Ribavirin
  • Brand Names Available In Australia: Ibavyr (Australia/New Zealand) — tablets 200 mg and 400 mg; Rebetol (found internationally) — capsules 200 mg and oral solution 40 mg/mL; Virazole (inhalation solution used in other markets).
  • ATC Code: J05AP01
  • Forms & Dosages: Capsule/Tablet 200 mg and 400 mg; Oral Solution 40 mg/mL; Inhalation Solution (Virazole) in markets where indicated.
  • Manufacturers In Australia: Ibavyr is found in Australia/New Zealand; international manufacturers include MSD (Rebetol), Roche (Copegus) and multiple generics from Apotex, Teva and Mylan.
  • Registration Status In Australia: Check the TGA ARTG for current registrations and specific authorised indications; international approvals include FDA and EMA for combination use in chronic hepatitis C.
  • OTC / Rx Classification: Prescription only (Rx).

Critical Warnings, Restrictions And Patient Protection (Australia)

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Is it safe for pregnant people or couples planning a family?

Ribavirin is absolutely contraindicated in pregnancy because it is teratogenic and can cause severe birth defects.

Both women of childbearing potential and male partners must use effective contraception during treatment and for six months afterwards.

A pre‑treatment pregnancy test is mandatory for females of childbearing potential.

Avoid ribavirin in severe renal impairment where creatinine clearance is below 50 mL/min.

Do not use in patients with haemoglobinopathies such as sickle cell disease or thalassaemia major.

Autoimmune hepatitis and concurrent didanosine use are absolute contraindications.

Elderly patients and those with cardiac or psychiatric disease need close monitoring and possible dose reduction.

Regular full blood counts are mandatory because ribavirin causes dose‑dependent haemolytic anaemia and can cause neutropenia and thrombocytopenia.

Counsel patients to watch for anaemia symptoms such as fatigue, breathlessness and chest pain, and to seek immediate medical review if these occur.

Immediate medical contact is required for severe side effects like collapse, chest pain or severe mood changes.

Use the following pre‑treatment checklist before starting therapy.

  • Pre‑treatment pregnancy test for females of childbearing potential.
  • Documented contraception counselling for patients and male partners.
  • Baseline renal function (eGFR/CrCl) and serum creatinine.
  • Baseline full blood count (haemoglobin, neutrophils, platelets).
  • Mental health screening and psychiatric history review.
  • Medication review for contraindicated drugs (notably didanosine).
  • Patient education on anaemia symptoms and when to seek urgent care.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will ribavirin affect my ability to work or drive?

Ribavirin may cause fatigue, dizziness and mood changes that can impair driving or the safe operation of machinery.

Under Australian workplace health and safety law, both employers and employees must manage impairment risks and not perform hazardous tasks if affected.

Advise avoiding hazardous activities until the individual knows how the medicine affects them.

  • Do not drive if you experience significant fatigue or dizziness.
  • Avoid operating heavy machinery until tolerance is established.
  • Avoid work at heights or in confined spaces while symptomatic.
  • Consider a temporary “fitness for work” note for employers where necessary.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Not until you know how it affects you.

If you experience significant fatigue, dizziness, blurred vision or mood changes, do not drive or operate heavy machinery and inform your prescriber and employer.

Seek immediate medical review for chest pain, collapse or sudden severe symptoms.

Usage Basics — Names, Forms And Legal Status

INN, Brand Names Available In Australia

Which brands and forms should Australian prescribers and pharmacists recognise?

Brand Form Strength
Ibavyr Tablet 200 mg, 400 mg
Rebetol Capsule; Oral Solution 200 mg; 40 mg/mL
Virazole Inhalation Solution Various inhalation strengths
Copegus Tablet 200 mg

Legal Classification (TGA‑Approved, PBS Context)

Ribavirin is prescription‑only in all countries listed and must be dispensed on an authorised prescription in Australia.

Check the TGA Australian Register of Therapeutic Goods (ARTG) for current registrations and indications before dispensing.

  • Confirm the product is ARTG‑listed for the intended formulation and indication.
  • Check whether the prescribed product is listed on the PBS for subsidy eligibility.
  • Confirm the route of administration and that the prescription matches authorised uses or an appropriate authority script.

Dosing Guide (Adult & Special Populations)

Standard Regimens (PBS Reference Dosing)

How is ribavirin dosed for chronic hepatitis C?

Weight Band Total Daily Dose Dosing Schedule
<75 kg 1000 mg/day Usually 400 mg morning, 600 mg evening
≥75 kg 1200 mg/day Usually 600 mg twice daily
Paediatric Approx. 15 mg/kg/day Divided doses with food

Ribavirin is always used in combination with interferon alfa or peginterferon alfa in the regimens described in historical references.

Typical durations are 48 weeks for genotypes 1, 4, 5 and 6, and 24 weeks for genotypes 2 and 3 when used in those stated combinations.

Adjustments For Comorbidities

Who needs dose changes or extra monitoring?

Avoid use in patients with creatinine clearance below 50 mL/min, or consider halving the dose with close monitoring where a specialist deems it appropriate.

Ribavirin is generally not recommended in decompensated liver disease.

Elderly patients require careful monitoring and possible dose reduction if comorbidities or renal decline are present.

  • Baseline CBC and renal function before starting therapy.
  • Monitor haemoglobin and renal function fortnightly in the early weeks, then monthly or per specialist protocol.
  • Monitor psychiatric status and cardiac symptoms regularly.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is almost time for your next dose.

Do not double the next dose to make up for a missed one.

If multiple doses are missed, contact your prescriber or pharmacist for advice.

For suspected overdose or severe adverse events, seek urgent medical attention or go to the nearest emergency department.

Interaction Chart — Food, Drink And Drug Conflicts

Food And Drinks (Alcohol, Australian Diet Context)

Does food or alcohol affect ribavirin?

Take ribavirin with food to reduce nausea and improve tolerability.

Alcohol does not have a direct pharmacokinetic interaction but it worsens liver disease and reduces treatment tolerability.

  • Avoid alcohol throughout hepatitis C therapy to protect liver health and improve outcomes.
  • Easily tolerated foods for nausea: plain toast, crackers, cold fruit, ginger biscuits, small frequent meals.

Common Drug Conflicts

Which medications must be avoided or adjusted?

Interacting Drug Interaction Type Clinical Action
Didanosine Absolute contraindication Do not co‑prescribe; stop didanosine before starting ribavirin.
Drugs That Worsen Anaemia (e.g. certain antiretrovirals) Increased anaemia risk Review therapy; increase monitoring and consider alternatives.
Renally Cleared Nephrotoxins (various) Reduced renal clearance increases ribavirin levels Assess renal function; avoid when CrCl <50 mL/min or halve dose.
Azathioprine Haematologic toxicity risk Use caution; consult specialist and monitor blood counts closely.
St John’s Wort (herbal) Potential induction of antivirals Advise patients to stop herbal products and check all OTC medicines.

User Reports And Trends — Australian Patient Feedback

What do Australian patients say about treatment with ribavirin?

Patient review sites, clinic surveys and health forums in Australia commonly mention treatment fatigue, dealing with anaemia, and mood changes as the main concerns.

Patients place high value on clear counselling from pharmacists and specialists and on PBS subsidy where available to reduce cost burden.

Rural patients report greater difficulty accessing timely specialist monitoring and pathology services.

  • Treatment fatigue and daytime sleepiness are commonly reported.
  • Concerns about anaemia and needing blood transfusions are raised in a minority of reports.
  • Mood changes and insomnia prompt many users to seek psychiatric review during therapy.
  • Access and cost are much improved when PBS criteria are met, according to many patient comments.
“The tablets made me very tired, but the pharmacist explained the blood test schedule and what to watch for, which helped.”

“Living two hours from the nearest hospital meant arranging local pathology and telehealth for my specialist — it was doable but a hassle.”

Clinicians should document and report suspected adverse reactions to the TGA Adverse Event Monitoring System.

Access And Purchase Options In Australia

National Chains And Community Pharmacies

Where can patients get ribavirin in Australia?

Major retailers such as Chemist Warehouse, Priceline and TerryWhite Chemmart dispense ribavirin on prescription and can order listed formulations.

  • Bring the authorised prescription and relevant concession card to check PBS eligibility.
  • Confirm stock availability and whether a generic or brand is preferred by the prescriber.
  • Arrange pathology requests and counselling appointment when collecting the first supply.

Online Pharmacies And Telehealth E‑Prescriptions

Can ribavirin be supplied online or via telehealth?

E‑prescriptions are accepted by pharmacies in Australia, and reputable registered online pharmacies can dispense on prescription.

In our online pharmacy, rebetol is available without a prescription, with discreet delivery to Australia in 9-21 days.

  • Verify the pharmacy is registered and displays AHPRA/TGA credentials.
  • Require government ID verification and a valid prescription before dispensing.
  • Use secure tracked delivery and advise patients about local blood test arrangements before the first dose.

Mechanism Of Action & Pharmacology (Plain English + Clinical)

Simplified Explanation

What does ribavirin do to the virus?

Ribavirin is a nucleoside analogue antiviral that interferes with viral RNA synthesis and replication.

It enhances the antiviral effect when combined with interferon or selected direct‑acting antivirals, improving sustained virological response in some regimens.

INN
Ribavirin
ATC
J05AP01
Mechanism
Nucleoside analogue that disrupts viral RNA replication.
Therapeutic Role
Adjunctive agent in combination regimens for chronic hepatitis C.

Clinical Terms And Implications

What should clinicians and patients understand clinically?

  • Ribavirin causes dose‑dependent haemolytic anaemia and requires regular full blood count monitoring.
  • Renal elimination is relevant; impaired renal function increases drug exposure.
  • Therapeutic drug monitoring is not routine, but laboratory follow‑up is essential.
  • Oral solution dosing affects accuracy in children and requires careful measurement.

Indications & Off‑Label Uses (Australian Practice)

Approved Indications By TGA (Practical Statement)

Ribavirin is used as part of combination therapy for chronic hepatitis C.

Confirm current local TGA registration and PBS indications before prescribing or dispensing.

Authorised Use Common Combination
Chronic Hepatitis C Ribavirin plus peginterferon alfa (historical); adjunct to selected DAAs in specific regimens

Off‑Label Uses In Australian Clinical Practice

Off‑label or compassionate uses are rare but possible in specialist settings.

Examples include inhalation use for severe RSV in specific settings where Virazole is indicated internationally.

  • Document the clinical rationale and obtain informed consent for any off‑label prescription.
  • Specialist oversight is required for compassionate or off‑label use.
  • Report outcomes and adverse effects to relevant authorities when used outside standard indications.

Key Clinical Findings (Recent Evidence & Practice Trends)

How has the role of ribavirin changed in recent years?

From 2022 to 2026, direct‑acting antivirals have largely supplanted ribavirin‑plus‑interferon regimens because of better efficacy and tolerability.

Ribavirin remains useful in selected genotypes, salvage regimens for decompensated disease or when resistance emerges to DAAs.

Clinicians should consult the latest Australian Hepatitis Guidelines and peer‑reviewed trials when selecting regimens.

Headline Trial Outcome Ribavirin Use
DAA Regimens Show Superior SVR Ribavirin less commonly required; used selectively to boost response in difficult cases
Salvage Regimens For Resistance Ribavirin retained as adjunct in some specialist protocols
  • Monitor for anaemia and psychiatric effects reported across studies.
  • Always check up‑to‑date national guidelines before altering standard practice.

Alternatives Matrix — DAAs And Ribavirin Comparators

PBS‑Listed Alternatives Comparison Table

Drug Indication Typical Duration PBS Subsidy Status Major Pros / Cons
Sofosbuvir Chronic HCV (various genotypes) 8–12 weeks typically PBS listed for many indications Pros: high efficacy, well tolerated. Cons: cost, drug interactions to review.
Ledipasvir/Sofosbuvir Genotype‑specific regimens 8–12 weeks PBS listed for selected indications Pros: high cure rates. Cons: cost and specific genotype targeting.
Glecaprevir/Pibrentasvir Pangenotypic DAA 8–12 weeks PBS listed for many cases Pros: pangenotypic, short duration. Cons: hepatic considerations in decompensation.
Ribavirin Adjunct in selected regimens 24–48 weeks depending on genotype and combination May be PBS‑listed when part of an authorised regimen Pros: adjunctive benefit in difficult cases. Cons: teratogenicity, anaemia, monitoring burden.
  • Checklist when choosing an alternative: efficacy, safety, tolerability, cost and monitoring requirements.
  • Ribavirin’s main disadvantages are teratogenicity and anaemia risk; its advantage is adjunctive activity in select regimens.

Common Questions From Australian Pharmacy Consultations

  • “Is it safe in pregnancy?” — No. Ribavirin is contraindicated in pregnancy; contraception is required for patients and male partners during treatment and for six months after therapy.
  • “How often are blood tests?” — Baseline blood tests then regular CBC and renal function monitoring; frequency set by the specialist (often fortnightly early, then monthly).
  • “Can I buy it over the counter?” — No. Ribavirin is prescription only and requires clinician supervision.
  • “What about side effects?” — Expect fatigue, anaemia and mood changes; report severe or worrying symptoms immediately.
  • For longer consultation: provide a printed handout and point patients to national guidance and their specialist team.

Price & Access Comparison (Pharmacy, Online, PBS)

Comparison Table — Source, Typical Price Range, PBS Subsidy, Prescription Required

Source Typical Out‑Of‑Pocket Range PBS Subsidy Prescription Required
Community Pharmacy Varies by brand/generic; moderate to high without PBS May apply for authorised regimens Yes
Chain Discount Pharmacy Lower cash price on generics May apply Yes
Registered Online Pharmacy Competitive pricing; delivery fees apply Depends on PBS eligibility Yes, valid prescription required
Hospital Supply Often subsidised or no direct cost to public patients Not applicable in same way Yes, hospital prescription

Access Checklist — Urban Vs Rural Availability

  • Confirm local stock at the preferred pharmacy before travel or dispensing.
  • Arrange courier delivery with secure packaging for oral solution if needed for rural patients.
  • Plan local blood tests through the GP or pathology service near the patient.
  • Discuss telehealth follow‑up and PBS script arrangements for rural patients.

Registration & Regulation (TGA, PBS, Reporting)

TGA Approval And Obligations

  • Check the TGA ARTG entry to confirm product registration and authorised indications.
  • Ensure products dispensed are ARTG‑listed or supplied under a Special Access Scheme where appropriate.
  • Report serious adverse events to the TGA and the manufacturer promptly.

PBS Subsidy Details And Documentation

  • Verify PBS listing and authority requirements before claiming subsidy.
  • Confirm patient concession eligibility and record the correct PBS item number.
  • Keep accurate dispensing records to meet PBS audit requirements.

Storage, Handling And Transport (Australian Climate)

Household Storage In Australian Heat/Humidity

Store ribavirin tablets, capsules and oral solution at 20–25°C and protect from excessive moisture and heat.

Keep medication away from direct sunlight and do not store in the car during hot weather.

  • Choose a cool, dry place in the house (not the bathroom).
  • Keep out of reach of children and label with the patient’s name.
  • Check expiry dates and discard any out‑of‑date medicine safely.

Cold‑Chain Handling For Pharmacies And Inhalation Products

Some inhalation products such as Virazole require cold‑chain handling per the product information.

  • Fridge temp ranges must be logged and validated in pharmacy storage areas.
  • Record temperatures and follow documented procedures for excursions.
  • Use validated insulated packaging for rural refrigerated deliveries and advise recipients to refrigerate on arrival.

Guidelines For Proper Use — Pharmacist Counselling & Patient Actions

Australian Pharmacist Counselling Style (Practical Script)

What should pharmacists say at the dispensing counter?

Explain the indication and that ribavirin is used in combination therapy for hepatitis C.

Confirm dosing schedule and advise taking tablets with food to reduce nausea.

Emphasise the absolute pregnancy contraindication and contraception requirements for both sexes.

Describe likely side effects: fatigue, anaemia and mood changes, and give clear instructions on when to seek urgent care.

Provide a written action plan with contact details for the prescriber and local pathology service.

  • Printed handout items: dosing, missed doses, blood test schedule, emergency symptoms, contraception checklist.

Patient Advice From PBS And National Health Authorities

PBS
Pharmaceutical Benefits Scheme — determines subsidy eligibility for treatments.
TGA
Therapeutic Goods Administration — regulator for registration and safety reporting.
ARTG
Australian Register of Therapeutic Goods — check for product registration.
CBC
Complete Blood Count — essential monitoring test during therapy.

Document consent and contraception counselling in the patient file prior to supply.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days

Related products